Relmada Therapeutics (RLMD) EV to FCF (2014 - 2026)

Relmada Therapeutics (RLMD) EV to FCF (2014 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to FCF
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-5.33 Mn
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-3.04 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-42,753.01
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-151,358.86
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-8,967.58
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	28.53
9	Abivax	90.15 Bn	90.15 Bn	-	-608.15
10	Relmada Therapeutics	575.00 Mn	575.00 Mn	-	-13.44

Download Data